CIO
SEPTEMBER 18, 2023
“It’s a win-win when you can get the long-term vision and growth of a company tied to individual career and professional development,” says Mark Yunger, vice president, head of IT at Servier Pharmaceuticals. From an individual’s perspective, it keeps careers interesting and helps people grow with the organization.
ArchIntel
JANUARY 26, 2021
The Greater Boston Area-based senior manager’s primary responsibilities include monitoring competitor and customer activities, direct threat assessments , and ensuring that the biotech company is in an optimal competitive position in terms of its product releases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ArchIntel
MARCH 9, 2021
“The global pharmaceuticals market size is expected to gain momentum by reaching USD 2,151.1 PharmaEssentia is looking for candidates with more than 10 years of experience in the pharma or biotech industry as a business insights, analytics and forecasting professional. ArchIntel™ -. billion by 2027 while exhibiting a CAGR of 7.0%
Fuld
NOVEMBER 1, 2022
Brad is a well-known commercial leader and influencer in the pharmaceuticals industry, especially in the fields of Infectious diseases, Immunology, and Vaccines. During his tenure at top pharmaceutical firms such as Pfizer and Merck, Brad was an integral part of the commercial introduction of blockbuster brands.
Sedulo
MARCH 15, 2023
2 Next, we grouped pharmaceutical sponsors/collaborators by their Scrip 100 industry rankings into two groups: top 20 pharma and all other pharma. Our Approach to this Analysis: We started by analyzing pharma-sponsored clinical trials, 1 initiated between 2018 and 2022, for only unapproved primary immuno-oncology (IO) drugs.
Evalueserve
DECEMBER 6, 2021
On the other hand, Biotech heavily underperformed post Q1’21 primarily due to the shifting of focus towards cyclicals and negative sentiments arising as of result of greater regulatory clampdown on transformative deals and drug pricing. These companies will be able to reshape the competitive landscape of the pharmaceutical industry.
BIS Research
MARCH 19, 2019
As it has successfully managed to bring together its different segments such as pharmaceutical & biotech, diagnostics, healthcare IT companies, care providers, hospitals, physicians and patients.
Expert insights. Personalized for you.
852 
Let's personalize your content